NASDAQ:CHTP

(CHTP) (CHTP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CHTP stock logo

About (CHTP) Stock (NASDAQ:CHTP)

Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.

CHTP Stock News Headlines

Elon to Transform U.S. Economy?
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Chelsea Therapeutics International (CHTP)
Elon to Transform U.S. Economy?
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Capiz flood leaves councilor dead
Queen Elizabeth Has Passed Away at 96
Diving finals: 10m Men
Toyota Prius
See More Headlines
Receive CHTP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CHTP) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CHTP
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

CHTP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (CHTP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CHTP) investors own include (AVNR) (AVNR), LadRx (CYTR), Dynavax Technologies (DVAX), Ariad Pharmaceuticals (ARIA), Avid Bioservices (CDMO), DryShips (DRYS), (GTATQ) (GTATQ), Intel (INTC), Plug Power (PLUG) and Rexahn Pharmaceuticals (REXN).

This page (NASDAQ:CHTP) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners